Learn more about Peter Attia’s digital program
#289 – AMA #56: Cancer screening: pros and cons, screening options, interpreting results, and more
“There has been a pretty clear and consistent benefit [to cancer screening] that has been demonstrated, and the exceptions I think have a pretty clear sense of why.” —Peter Attia
#286 ‒ Journal club with Andrew Huberman: the impact of light exposure on mental health and an immunotherapy breakthrough for cancer treatment
“People spend 90% of their time indoors now. Their daytime environments are too dim, their nighttime environments are too bright.” —Andrew Huberman
More than glycemic control: SGLT2 inhibitors may extend lung cancer survival
A retrospective study offers hope
#267 ‒ The latest in cancer therapeutics, diagnostics, and early detection | Keith Flaherty, M.D.
“Early detection is going to allow our same toolbox of drugs to be massively more effective.” —Keith Flaherty
#216 – Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.
“My big hope is that we’re going to be able to have some combination of directed, metabolic immune supplements and diet that really work with therapy to treat cancer.” —Josh Rabinowitz